Adrie van Bokhoven, PhD The PCA3 assay could be particularly useful in finding prostate cancer sooner in African Americans. DENVER – The PCA3 urine test may improve early detection of prostate cancer, ...

March 30, 2007 — A new test for prostate cancer, which measures levels of the prostate cancer gene 3 (PCA3) in urine, may be useful in diagnosing prostate cancer in men who have elevated serum levels ...

Prostate cancer metastasis, the noncanonical Wnt pathway, and the transcription factor PITX2. Background: Several studies using APTIMA PSA assay have demonstrated that PCA3 score is superior to serum ...

Effect of MDV3100, an androgen receptor signaling inhibitor (ARSI), on overall survival in patients with prostate cancer postdocetaxel: Results from the phase III AFFIRM study. Background: Active ...

WASHINGTON (Reuters) - A urine test can help doctors better spot prostate cancer than either the current blood test or a rectal exam alone, U.S. researchers reported on Tuesday. They said Gen-Probe's ...

February 7, 2008 — Novel urine biomarker tests can detect prostate cancer more accurately than other currently available screening methods, researchers report. Results of a study published in the ...

DiagnoCure reported positive data at the American Urological Association (AUA) meeting from a multicenter study to independently validate the Progensa PCA3 assay for the detection of prostate cancer ...

Test aims to help clinicians decide whether patients who test negative will need further biopsy procedures. FDA approved Gen-Probe’s Progensa® PCA3 (Prostate Cancer gene 3) assay, which the firm ...

When 54-year-old Jeff Rolf went in for his annual physical three years ago, he did not expect to come away with news of an abnormal PSA level and, eventually, a prostate cancer diagnosis. But the ...

Arnhem, 16 October 2008 – Prostate cancer (PCa) is one of the most common male cancers in the Western world. Currently, early detection of PCa depends on an abnormal digital rectal examination and an ...

In the European Randomised Study of Screening for Prostate Cancer (ERSPC) trial, PCA3 was assessed as a first line-screening test. 40 While the positive predictive values of a PCA3 score of 10 or ...